Skip to main content

ORIGINAL RESEARCH article

Front. Immunol., 15 December 2023
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Rapid screening for autoimmune diseases using Fourier transform infrared spectroscopy and deep learning algorithms

Xue Wu,Xue Wu1,2Wei ShuaiWei Shuai3Chen ChenChen Chen4Xiaomei Chen,Xiaomei Chen1,2Cainan Luo,Cainan Luo1,2Yi Chen,Yi Chen1,2Yamei Shi,Yamei Shi1,2Zhengfang Li,Zhengfang Li1,2Xiaoyi LvXiaoyi Lv3Cheng ChenCheng Chen3Xinyan Meng,Xinyan Meng1,2Xin Lei,Xin Lei1,2Lijun Wu,*Lijun Wu1,2*
  • 1Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China
  • 2Graduate School of Xinjiang Medical University, Urumqi, Xinjiang, China
  • 3College of Software, Xinjiang University, Urumqi, Xinjiang, China
  • 4College of Information Science and Engineering, Xinjiang University, Urumqi, Xinjiang, China

Introduce: Ankylosing spondylitis (AS), rheumatoid arthritis (RA), and osteoarthritis (OA) are three rheumatic immune diseases with many common characteristics. If left untreated, they can lead to joint destruction and functional limitation, and in severe cases, they can cause lifelong disability and even death. Studies have shown that early diagnosis and treatment are key to improving patient outcomes. Therefore, a rapid and accurate method for rapid diagnosis of diseases has been established, which is of great clinical significance for realizing early diagnosis of diseases and improving patient prognosis.

Methods: This study was based on Fourier transform infrared spectroscopy (FTIR) combined with a deep learning model to achieve non-invasive, rapid, and accurate differentiation of AS, RA, OA, and healthy control group. In the experiment, 320 serum samples were collected, 80 in each group. AlexNet, ResNet, MSCNN, and MSResNet diagnostic models were established by using a machine learning algorithm.

Result: The range of spectral wave number measured by four sets of Fourier transform infrared spectroscopy is 700-4000 cm-1. Serum spectral characteristic peaks were mainly at 1641 cm-1(amide I), 1542 cm-1(amide II), 3280 cm-1(amide A), 1420 cm-1(proline and tryptophan), 1245 cm-1(amide III), 1078 cm-1(carbohydrate region). And 2940 cm-1 (mainly fatty acids and cholesterol). At the same time, AlexNet, ResNet, MSCNN, and MSResNet diagnostic models are established by using machine learning algorithms. The multi-scale MSResNet classification model combined with residual blocks can use convolution modules of different scales to extract different scale features and use resblocks to solve the problem of network degradation, reduce the interference of spectral measurement noise, and enhance the generalization ability of the network model. By comparing the experimental results of the other three models AlexNet, ResNet, and MSCNN, it is found that the MSResNet model has the best diagnostic performance and the accuracy rate is 0.87.

Conclusion: The results prove the feasibility of serum Fourier transform infrared spectroscopy combined with a deep learning algorithm to distinguish AS, RA, OA, and healthy control group, which can be used as an effective auxiliary diagnostic method for these rheumatic immune diseases.

GRAPHICAL ABSTRACT
www.frontiersin.org

Graphical Abstract

1 Introduction

Ankylosing spondylitis (AS), rheumatoid arthritis (RA), and osteoarthritis (OA) are three similar chronic inflammatory diseases. AS is an autoimmune disease that affects tendon attachment points, mainly manifesting as sacroiliac joint inflammation and chronic spondylitis (1). It is more prevalent in young men. Conversely, RA is a chronic autoimmune disease characterized by erosive arthritis (2), with a high prevalence in women. OA, meanwhile, is a degenerative joint disease with lesions in the cartilage (3), which presents with degenerative changes in the cartilage, secondary synovitis, bone metaplasia forming bony encumbrances, and, in more severe cases, causing cystic changes and destruction of the subchondral bone. It is a significant cause of disability in both the elderly and young people (4). These three rheumatic diseases are common musculoskeletal disorders worldwide, with the peak incidence of AS and RA occurring in young and middle age, where patients have arthritis, spinal stiffness, and deformity, ultimately leading to severe disability and, consequently, a substantial financial burden on families. According to the literature, osteoarthritis is the eleventh risk-ranked disability factor globally (5). The increasing prevalence of OA poses a substantial challenge to the health of middle-aged and elderly individuals. Since there is a lack of adequate clinical cures for AS, RA, and OA, early screening remains the only available option to alleviate the condition of patients.

In studies used to diagnose ankylosing spondylitis (AS), specific markers such as human leukocyte antigen B27 (HLA-B27) and C-reactive protein (CRP) are positive in 85-95% of AS patients (6). However, in most other autoimmune disease patients, they also were significantly positive (7, 8), indicating that they may not be reliable indicators for diagnosing AS or determining the effectiveness of treatment. The diagnosis of RA is based on the patient’s symptoms, test results, family history, and assessment of risk factors. For example, elevated CRP and ESR levels in serum tests (9) and the presence of RA-specific autoantibodies (10) can contribute to the diagnosis. Additionally, the use of ultrasound (11) and magnetic resonance imaging (MRI) (12) has been helpful in monitoring and diagnosing disease activity in RA patients. These diagnostic methods offer advantages such as relatively low cost, high usability, and real-time imaging capability (13). However, it depends on the operator’s skill and requires rigorous training in measurement and quality assessment. Currently, the gold standard for the diagnosis of OA mainly includes X-ray imaging (plain X-ray film), MRI, routine clinical examination of symptomatic joints (14), etc. X-ray imaging is considered safe, cost-effective, and widely accessible. However, radiographs are not very sensitive in detecting the early stages of OA (5), and interpreting the images requires a skilled practitioner.

Serological biomarkers and medical imaging are the primary diagnostic methods for three rheumatological immunological diseases: AS, RA, and OA. However, these methods have drawbacks, such as complexity, invasiveness, and reliance on the operator’s skills. It is, therefore, necessary to identify a simple, rapid, and non-invasive method to differentiate between AS, RA, and OA, as well as healthy controls, to diagnose these diseases early.

In recent years, the application of FTIR spectroscopy for the non-invasive, efficient, and rapid screening of rheumatic and immune diseases has gained attention from researchers (15, 16). Fourier transform infrared (FTIR) spectroscopy is a non-invasive, cost-efficient, and highly available technology (17). It assesses the individual biomolecules of a sample by analyzing the vibrational and rotational level changes in infrared absorption (18). FT-IR spectroscopy can measure differences in serum composition and detect abnormalities in specific molecules in proteins, lipids, nucleic acids, and other key markers of pathogenesis (19). FTIR was used for the diagnosis of many diseases and material testing. For instance, Francesco et al. (20) discovered microcalcifications in human ovarian plasma tumor tissues containing amorphous calcium carbonate phosphate, employing micro-Fourier transform infrared spectroscopy (micro-FTIR). Alla et al. (21) combined FTIR with colonoscopy and found from spectral analysis that spectral differences in the collagen fraction could be used for early and rapid screening of colorectal cancer. Studies have utilized FTIR to achieve earlier diagnosis of RA and OA, respectively (15, 16). Still, there is a lack of studies on the differentiation of similar rheumatic immune diseases. Highly accurate differentiation of AS, RA, OA, and healthy controls is vital for early treatment. However, owing to the low signal-to-noise ratio characteristic of most spectral signals (22), it is difficult to observe the differences between the spectra of several similar rheumatic diseases, likely leading to poor diagnosis. Therefore, designing a method to achieve high accuracy in diagnosing AS, RA, and OA disorders using FTIR is vital.

Machine learning is an approach to analyzing features through algorithms, learning the laws of data distribution, and making decisions or predictions based on specific tasks. With the continuous progress of computer technology research, the application of machine learning combined with FTIR spectroscopy in medical research is rapidly expanding. It can even replace the traditional methods used to diagnose various diseases. However, when the distinctions between the FTIR spectroscopy of the pieces are very small or even challenging to be observed by the human eye, the results achieved by simple machine learning algorithms cannot meet the diagnostic requirements, e.g., Support Vector Machines, Principal Component Analysis, K-Nearest Neighbors (2325), and so on. Deep learning belongs to a class of methods in machine learning which solves many problems that traditional machine learning algorithms are ineffective at through its complex model structure. Deep learning methods combined with FTIR spectroscopy have been widely employed in disease screening. For example, Rose G et al. (26) utilized attenuated total reflection Fourier transform infrared (FTIR) spectroscopy to validate that the Wasserstein generative adversarial network enhancement method improves the accuracy of convolutional neural networks in distinguishing pancreatic cancer from non-cancerous samples. Hu et al. used convolutional neural networks combined with computed tomography (CT) to detect osteoporotic vertebral compression fractures (OVCF), achieving an accuracy of 81.70% on an independent test set (27). Wang et al. used a dual-mode model (MP-NN) to integrate serum metabolic fingerprints (SMFs) with protein tumor marker carcinoembryonic antigen (CEA) for the diagnosis of early lung adenocarcinoma and classification of lung nodules. Then based on MP-NN, the three-mode model MPI-RF, which uses random forest to integrate SMFs, CEA and image features, is superior to clinical diagnosis in the classification of pulmonary nodules (28). Yang et al. (29) classified the tissue transformation stages of esophageal squamous cell carcinoma with high accuracy based on a one-dimensional convolutional neural network (1-CNN) combined with micro-FTIR. Chen et al. (30) used an improved multi-scale fusion convolutional neural network on near-infrared spectral data to classify cumin and cumin with an accuracy of 100%. So far, most studies have been limited to classifying single diseases with healthy controls, and diagnostic models lack network improvement and comparison. For this reason, it is also interesting to design a deep learning model that is more suitable for classifying multiple rheumatologic diseases.

This study developed a multi-scale (MS) ResNet network structure based on FTIR spectra to accurately classify AS, RA, OA, and healthy controls. The model was designed to address two main challenges: substantial noise interference in the spectral measurement process and the high similarity among the three rheumatological diseases. To effectively handle these challenges, the model incorporates three multi-scale convolutional modules with different numbers of filters and convolutional kernel sizes. These modules are responsible for extracting features of different scales. Additionally, a residual block (ResBlock) is used to overcome the problem of network degradation. This block enables the extraction and fusion exploitation of local features, reducing noise interference in the spectral data and enhancing the model’s generalization ability. To ensure the superiority of the proposed MSResNet model, three other mainstream models (AlexNet, ResNet, and MSCNN) are selected for this experiment to compare the results.

2 Materials and methods

2.1 Sample preparation

This study obtained 80 serum samples each from AS, RA, OA, and healthy controls from the Department of Rheumatology and Immunology of Xinjiang People’s Hospital. The serum samples were centrifuged at high speed for 10 minutes at a temperature of 4 , and the supernatant layer was stored in a refrigerator at a temperature -80 overnight. During the assay, serum samples are thawed inherently at a consistent room temperature of 22 . Subsequently, 5 μL of the sample was pipetted onto the FTIR spectrometer. After 10 minutes of natural drying, the spectra were collected. The samples for this study were obtained from the People’s Hospital of Xinjiang Uygur Autonomous Region and ethical approval was obtained (KY2021101507).

2.2 Fourier transform infrared spectroscopy acquisition

The infrared spectra of serum were acquired by an FTIR spectrometer (FTIR-850, Gangdong Scientific, China), with air as the background, in the spectral range of 700-4000 cm-1, with 32 scans and a resolution of 4 cm-1. To reduce the noise interference in the acquisition process, all the samples were acquired once at three different positions, and the average value was taken as the infrared spectrum of that sample. Finally, 80 FTIR spectra of each of the serum samples from AS, RA, OA, and healthy control serum samples were obtained in this study, totaling 320 spectral samples.

2.3 Classification model

2.3.1 AlexNet

AlexNet is a feed-forward neural network established on Convolutional Neural Networks that mimics biology. It has convolutional computation and a deep structure (29) and is widely employed in image and natural language processing, among other areas. The network structure of AlexNet has convolutional primarily, pooling, and fully connected layers. The convolutional layer extracts information from the input data through filters (31), mapping local features from the previous layer to the next layer. The two parts of the convolutional layer, local connectivity, and weight sharing, dramatically reduce the number of parameters and the computational burden of complex nonlinear transformations. The AlexNet model framework proposed in this study is shown in Figure 1, which primarily includes three convolutional layers. The filters are 32, 64, and 128, respectively, and the kernel size is set to 3. Behind each layer, a batch normalization layer, and a max-pooling layer with a kernel of 2 are connected. The Flatten layer then one-dimensional the multi-dimensional input, reduce overfitting using the Dropout layer, and output the classification results through two Dense layers.

Figure 1
www.frontiersin.org

Figure 1 AlexNet framework structure diagram: consisting of three convolutional layers, with 32, 64, and 128 filters, and a kernel size of 3. After each layer, a batch normalization layer and a maximum pooling layer with a kernel size of 2 are connected, with a Dropout value of 0.4 to prevent model overfitting.

2.3.2 ResNet

As deep learning models are applied in more complex domains, the depth of the network layers is increasing. During the backpropagation process, the gradient gradually diminishes, making the weight update of the shallow network almost ineffective. This increases training difficulty for the deep model, known as the gradient vanishing problem (32). To solve this, He et al. (33) proposed the ResNet model, which achieved significant results in the 2015 ImageNet image recognition competition. The ResNet model is based on the traditional CNN model and introduces the “residual block”. This block allows information to bypass one or more layers in the network, reaching the output directly. The ResNet model enables faster convergence and better performance by allowing the network to learn the residual function and make minor parameter updates. The structure of the Residual Block (ResBlock) used in this experiment is shown in Figure 2. The main branch consists of two convolutional layers and a Batch Normalization layer. There is also a shortcut branch, which has only one convolutional layer, and its parameters are the same in each ResBlock structure. Finally, the extracted multi-scale features are fed into the Flatten layer and classified by the Dense layer.

Figure 2
www.frontiersin.org

Figure 2 ResNet framework structure diagram: including one convolutional layer and three ResBlock layers, where the convolutional layer has a kernel size of 9, 24 filters, and a maximum pooling layer kernel size of 3. The convolution kernel size in all three ResBlock layers is 3, and the number of filters is 32, 64, and 128, respectively. Finally, using average pooling to extract overall features.

2.3.3 MSCNN

As a particular type of neural network that incorporates convolutional computations, CNN has a strong capability for feature extraction. The network’s structure, characterized by parameter sharing and local connectivity, helps to reduce computational load, thereby enhancing CNN’s generalization ability in various application domains. However, traditional CNN models tend to lose important information from the original data during training (34). Additionally, extracting multi-scale features proves challenging, resulting in reduced efficiency. MSCNN builds on the concept of multicolumn DNN to extract multi-scale signals. This is achieved using three parallel convolutional layers with varying sensory field sizes. The structure of these three convolutional layers remains the same, comprising a Conv1d layer, a BatchNormalization layer, and a pooling layer. The multi-scale features are then merged in the Concatenate layer. Furthermore, the features extracted by the three convolutional layers are inputted to the Flatten layer, with overfitting addressed by incorporating the Dropout layer. Finally, the classification results for the spectral data are obtained through the two Dense layers. The MSCNN network framework is shown in Figure 3.

Figure 3
www.frontiersin.org

Figure 3 MSCNN framework structure diagram: including three parallel receptive fields, using convolution kernels of sizes 3, 7, and 9 to extract features of different scales. Each parallel convolution layer consists of Conv1d layers, BatchNormalization layers, and pooling layers. Integrate multi-scale features in the Concatenate layer.

2.3.4 MSResNet

The MSResNet model proposed in this paper is designed based on ResNet, concerning the MSCNN model feature extraction, combining multi-scale information extraction with a residual structure to achieve a high-accuracy diagnosis of diseases. This multi-scale convolutional kernel design has been proven to work better in fields such as image recognition (35, 36). The MSResNet network framework is shown in Figure 4, where three convolutional kernels of different sizes are used instead of a single convolutional kernel to extract feature information at different scales. The fused multi-scale features are input into the ResNet structure to enhance the model implementation using the unique residual design.

Figure 4
www.frontiersin.org

Figure 4 MSResNet framework structure diagram: using three convolutional kernels of different sizes instead of a single kernel to extract feature information at different scales. Then input the fused multi-scale features into the ResBlock block to improve model performance.

2.4 Spectral analysis

A total of 320 patients were included in this study, including 80 patients in the AS, RA, OA, and HC groups, with an average age of 40.5 ± 6.0 years old and a male to female ratio of 1.1:1. There was no statistically significant difference in age and gender among the four groups, as shown in Table 1. Figure 5 shows FTIR spectra of serum samples from AS, RA, OA, and healthy controls. The measured spectral wave number interval is 700-4000 cm-1, a wave number range containing a wealth of information on biomolecular fingerprints, such as proteins, lipids, carbohydrates, and nucleic acids in serum, identifying the disease category. The spectral curves of the four types are similar, with the primary distinction being the magnitude of the curve fluctuations. Figure 6 shows the average spectral comparison of serum samples from three types of diseases and healthy controls (HC). The characteristic peaks of serum spectra are mainly at 1078, 1245, 1400, 1542, 1641, 2940, and 3280 cm-1, and Table 2 lists the tentative material assignments for these major FTIR peaks. The most substantial characteristic peaks are at 1641 cm-1 (amide I) and 1542 cm-1 (amide II) (37, 38), which represent the stretching and bending vibrations on the amide C=O as well as the N-H groups of proteins, respectively (39), the broadband at 3280 cm-1 also corresponds to the N-H group, but it is a stretching vibration (40) and is referred to as the amide A mode; the vicinity of 1420 cm-1 represents the region of proteins, phosphate molecules, and fatty acids (16), and it has been illustrated that this wavelength is related to proline and tryptophan in proteins; 1245 cm-1 represents amide III, the asymmetric P=O stretching in PO2 (25); 1078 cm-1 represents the region of carbohydrates (15); and the area of 2940 cm-1 is dominated by fatty acids and cholesterol, among other substances (41).

Table 1
www.frontiersin.org

Table 1 Age, gender, and statistical information of the samples.

Figure 5
www.frontiersin.org

Figure 5 Average spectra (lines) and area of spectral regions (shaded) for all samples for ankylosing spondylitis (AS), rheumatoid arthritis (RA), osteoarthritis (OA), and healthy control (HC) serum samples.

Figure 6
www.frontiersin.org

Figure 6 Comparison of average spectra of serum samples from ankylosing spondylitis (AS), rheumatoid arthritis (RA), osteoarthritis (OA), and healthy controls (HC).

Table 2
www.frontiersin.org

Table 2 Peak positions and tentative assignments of major FTIR bands.

2.5 Experimental setup

This experimental dataset consists of Fourier transform infrared spectra of serum samples from patients with AS, RA, OA, and healthy controls, and the four types of data were classified by AlexNet, ResNet network, multi-scale convolutional neural network, and multi-scale ResNet network. In addition, most of the typical medical studies of infrared spectroscopy are based on small datasets, insufficient training data can result in providing less valid information, and model training is prone to overfitting. To alleviate overfitting, five-fold cross-validation is used in the training process to improve the model’s generalization ability. The data set is divided into the training set and the test set in a 7:3 ratio, and the training set is used for cross-validation. It is randomly divided into five, four for training and one for validation. The training process batch size was set to 8, epoch to 200, optimizer to Adam, and learning rate to 0.0001. To compare the performance of the different models more intuitively, the experiments were compared by the subjects’ work characteristic curve (ROC) and area under the curve (AUC), accuracy, sensitivity, precision, and specificity metrics. ROC is a probability curve that shows the classification ability of a model curve. The AUC value is expressed as the area under the ROC curve; a larger AUC indicates a better classification model performance.

2.6 Classification results

The classification results of the four models, namely AlexNet, ResNet, MSCNN, and MSResNet, are presented in Figures 7A, B. Figure 7A displays the ROC curves of the models, with all models achieving AUC values exceeding 0.9. The highest AUC value, 0.98, is obtained by MSResNet. Figure 7B illustrates the accuracy, sensitivity, precision, and specificity metrics of the models’ classification. The specificity values for all four models exceed 0.9. However, the other three metrics, namely accuracy, sensitivity, and precision, show poorer results for AlexNet and ResNet compared to MSResNet. MSResNet demonstrates the best performance across all metrics, with values of 0.8854, 0.8749, 0.8829, and 0.9617 for accuracy, sensitivity, precision, and specificity, respectively. To further evaluate the models’ classification on the four types of samples, Table 3 presents the classification accuracy and average value for each model. MSResNet achieves the highest average accuracy of 0.8749 and performs better in classifying the two types of samples, AS and HC. Comparing the evaluation metrics of all the models, it can be concluded that MSResNet exhibits the most effective classification for the four types of samples, namely AS, RA, OA patients, and Healthy Controls.

Figure 7
www.frontiersin.org

Figure 7 (A) plots the ROC curve of the model, and the AUC value represents the area under the ROC curve. The larger the AUC value, the better the generalization performance of the model. (B) shows the four evaluation index values of accuracy, sensitivity, precision, and specificity of model classification. The higher the accuracy value, the better the classification performance of the model.

Table 3
www.frontiersin.org

Table 3 Accuracy and mean values of the classification of the model for the four types of AS, RA, OA patients, and HC, with best results in bold.

3 Discussion

AS, RA and OA are all common chronic inflammatory diseases that cause joint and bone abnormalities, often resulting in severe disability. They are the leading causes of chronic disability worldwide. However, if diagnosed early and treated promptly, the likelihood of disability or life-threatening damage can be greatly reduced. Unfortunately, there is currently no validated and unambiguous method to differentiate between AS, RA, OA, and healthy individuals. Therefore, there is a critical need for affordable and reliable detection methods, particularly in the early stages of these diseases. In vibrational spectroscopy, the chemical bonding of molecules in a sample can be examined without the need for labeling (42). This technique enables the distinction between diseased and healthy individuals by identifying specific wavefronts that are believed to be associated with disease specificity. Through the analysis of these distinct peaks, it is possible to identify disease-related chemicals, including proteins, nucleic acids, carbohydrates, and lipids. These specific regions in the spectrum can be considered as unique “fingerprints” of the disease. Overall, vibrational spectroscopy holds promise as a potential method for the early detection of AS, RA, and OA, as it allows for non-invasive and accurate identification of disease-specific markers (43). In this study, the first attempt was made to design an MSResNet network structure based on a multiscale and residual structure to efficiently differentiate sera from AS, RA, and OA patients as well as healthy controls by Fourier transform infrared spectroscopy and spectral analysis. By comparing with three other mainstream models (AlexNet, ResNet, MSCNN), MSResNet was found to have better diagnostic performance.

During the experiment, common and specific discriminatory waveforms were identified for the four samples through spectral analysis (Table 1). The common waveforms were observed because these diseases share certain common features and are all chronic joint inflammatory diseases. The specific waveforms were not readily apparent in the analysis, and the main difference among the four samples was the peak size of the common waveforms. For example, peaks were observed at 1641 cm-1 (amide I), 1542 cm-1 (amide II), 3300 cm-1 (amide A), 1420 cm-1 (proline and tryptophan), 1245 cm-1 (amide III), 1078 cm-1 (carbohydrates), and 2940 cm-1 (fatty acids and cholesterol). These substances have been identified in previous studies as signaling molecules for cell growth, differentiation, and apoptosis. It has been demonstrated that they induce synovial cell apoptosis by modulating diverse signaling pathways (44). Additionally, using electrospray ionization mass spectrometry for synovial tissue analysis, it has been found that amide levels are elevated in patients with RA and OA, and reduced in patients with AS (45). The relative intensity increase observed between the Raman bands located at 1241 cm-1and 1269 cm-1 (amide III doublet) by Takahashi et al. may be associated with structural changes under type II collagen loading. This suggests a higher content of disordered collagen in the cartilage of osteoarthritis (OA) patients (46). This is indeed evidence of collagen defects leading to abnormal cartilage structure. This finding indicates that current spectroscopic methods may contribute to identifying and quantitatively assessing the early manifestations of osteoarthritis. In addition, a study on non-targeted lipidomics analysis of synovial fluid and serum from rheumatoid arthritis (RA) patients at different disease activities and clinical stages (from pre-clinical to active to sustained remission) revealed that the lipidomic profile in RA joint fluid is correlated with the degree of inflammation and the severity of synovitis. Changes in amide levels can predict the therapeutic response to drugs (47). These results suggest that monitoring amide levels may aid in disease identification, predicting the evolution from pre-clinical to definitive disease, and assessing disease activity and treatment outcomes.

This study also revealed significant differences in four groups at 1420 cm-1 (proline and tryptophan). Amino acid metabolism is considered a key regulator of both innate and adaptive immune responses (48). Proline, abundant in the body and second only to glutamine and alanine, constitutes 50% of collagen in the body, approximately 30% of the body’s total protein. As collagen is a major component of cartilage, it plays a crucial role in constructing the cartilage tissue framework, supporting joint loading, and protecting and repairing damaged joint cartilage. Abnormal proline metabolism can lead to a reduction in collagen, resulting in decreased resistance of connective tissues, abnormal bone collagen metabolism, and the onset of chronic orthopedic diseases such as OA and RA. Hydroxyproline, a metabolic product of proline, serves as a marker for collagen degradation (49). On the other hand, tryptophan, an essential amino acid in the human body (50), has metabolites with immune, metabolic, and neuroregulatory functions in biology, making it a therapeutic target for various diseases. As early as the late 1950s, scholars proposed the use of the tryptophan content in synovial fluid to distinguish between inflammatory and non-inflammatory joint diseases. This is particularly relevant in the tryptophan metabolism pathway mediated by rate-limiting enzymes indoleamine-2,3-dioxygenase1(IDO1), indoleamine-2,3-dioxygenase2(IDO2), tryptophan-2,3-dioxygenase (TDO), and kynurenine monooxygenase (KMO). Studies have found that changes in serum tryptophan are closely related to disease progression, with the progression of RA leading to decreased tryptophan levels due to IDO1-induced tryptophan degradation (51), providing important theoretical basis for identifying diagnostic and therapeutic biomarkers for RA. In OA patients, increased protein hydrolysis may produce more free tryptophan in the intestines (52), leading to an overall increase in tryptophan and its metabolites. Additionally, research indicates that tryptophan metabolites indole-3-acetaldehyde and indole-3-acetic acid are involved in the occurrence and development of spondyloarthritis (SPA) (53). These research findings suggest that abnormal proline and tryptophan metabolism play crucial roles in the pathological mechanisms of RA.

Finally, this study observed differences in the peak at 2940 cm-1 (fatty acids and cholesterol) among the four groups, consistent with previous research. Studies have demonstrated the involvement of lipid metabolism in the onset of RA and AS. Abnormalities in lipid metabolism in immune cells contribute to the invasion and migration of synovial tissues in RA patients, promoting synovial inflammation, as well as cartilage and bone erosion. In RA patients, the synovium shows significantly higher levels of palmitic acid, total saturated fatty acids, long-chain MUFA, and/or total MUFA compared to osteoarthritis and healthy control groups. Conversely, in AS patients, the concentrations of many lipids decrease (54, 55). In summary, the above studies indicate that FTIR optimized with machine learning algorithms could serve as a convenient, rapid, and economical detection method for monitoring changes in substances such as amino acids and lipids in patients. This approach holds promise for disease diagnosis and prognosis research.

Many studies have reported the application of spectroscopic techniques in rheumatic diseases. Lee et al. (56) measured by Raman micro spectroscopy that the mineralization of subchondral trabecular bone (SCTB) tissues in osteoarthritis regions in knee osteoarthritis was markedly lower than that of the corresponding regions in control individuals, further demonstrating the potential value of SCTB for targeted therapies in OA. Cao et al. (57) utilized a multivariate dimensionality reduction method and a machine learning algorithm to analyze the correlation between spectral differences and clinical and immunological manifestations in RA patients. Prada et al. (41) developed the first prediction model for LDA based on FTIR with diagnostic accuracies of 97% and 85% for two diseases, namely Crohn’s disease (CD) and spondylarthritis (SpA), respectively. Collection of blood samples is non-invasive and simple, therefore spectroscopy-based disease diagnosis is easily reproducible and cost-effective. To this end, this experiment designed a multiscale combined residual block MSResNet model based on FTIR spectra to achieve high-performance classification of AS, RA, OA, and HC. The model effectively combines the multiscale module in a multiscale convolutional neural network with the ResNet model. The multiscale module consists of three convolutional layers with different numbers of filters and convolutional kernel sizes, which facilitates the extraction of multiscale and multilevel features. On the other hand, the residual block in the ResNet model avoids the deep model network degradation problem. With these designs, the MSResNet model achieves the extraction and fusion of local features of the four samples, which mitigates the effects brought by the noise of spectral data to enhance the generalization ability of the model diagnosis.

4 Conclusions

In this paper, we propose a robust method capable of differentiating between patients with AS, RA, and OA, as well as healthy controls. Firstly, the FTIR of the four serum samples was measured using a spectrometer, and then a multiscale residual convolutional neural network (MSResNet) was constructed to classify the spectral data. The model mainly consists of a multiscale module and a residual block, the multiscale module uses three sets of convolutional layers with different specifications to extract richer multiscale feature information, followed by a residual block used to solve the network degradation problem brought by the simple deep model. In addition to this, this study also conducts comparison experiments with three other models (AlexNet, ResNet, and MSCNN). The experimental results show that using a multi-scale feature fusion model outperforms the traditional ResNet framework that extracts features using only one scale, and the multi-scale combined residual block model also outperforms the simple MSCNN model. This fully demonstrates the superiority of our model for high similarity spectral classification, which enables non-invasive, fast, and low-cost identification of four types of data, namely ankylosing spondylitis, rheumatoid arthritis, osteoarthritis, and healthy control group, by extracting their multi-scale and multi-level features from the spectral data. The spectral analysis also revealed that amides, proline, and tryptophan are likely to be spectral “biometric fingerprints”, and thus FTIR may be a promising tool for the study of rheumatic diseases as a rapid, low-cost, and accurate biomarker identification method, and may also provide effective information for prognostic examinations. Although this article has detailed and validated the effectiveness of using FTIR method to diagnose several autoimmune diseases, early detection systems using FTIR combined with deep learning algorithms still require deeper and more extensive validation for treating other diseases.

Data availability statement

The data analyzed in this study is subject to the following licenses/restrictions: Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available. Requests to access these datasets should be directed to Xue Wu,wuxue199094@163.com.

Ethics statement

The studies involving humans were approved by Ethics Committee of Xinjiang Uygur Autonomous Region People’s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

XW: Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing. WS: Methodology, Software, Writing – original draft. CC: Data curation, Supervision, Writing – review & editing. XC: Data curation, Formal Analysis, Writing – review & editing. CL: Writing – review & editing. YC: Formal Analysis, Supervision, Writing – review & editing. YS: Project administration, Resources, Writing – review & editing. ZL: Formal Analysis, Investigation, Writing – review & editing. XYL: Resources, Supervision, Writing – review & editing. CgC: Methodology, Resources, Supervision, Writing – review & editing. XM: Formal Analysis, Validation, Writing – review & editing. XL: Writing – review & editing. LW: Methodology, Resources, Supervision, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Key Research and Development Project of Xinjiang Uygur Autonomous Region (2022B03002-1), the Youth Science Fund of Natural Science Foundation of Xinjiang Uygur Autonomous Region (2022D01C144) and National Key R&D Program of China (2022YFC3602000).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Deodhar A, Kruzikas D, Zhou L, Biljan A, Saffore CD. Geographic variations in diagnosis and treatment of ankylosing spondylitis in the United States: A real-world study. Rheumatol Ther (2022) 9:447–63. doi: 10.1007/s40744-021-00406-9

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Lin Y-J, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells (2020) 9. doi: 10.3390/cells9040880

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Karim M, Jiao J, Döhmen T, Cochez M, Beyan O, Rebholz-Schuhmann D. DeepKneeExplainer: explainable knee osteoarthritis diagnosis from radiographs and magnetic resonance imaging. IEEE Access (2021), 39757–80. doi: 10.1109/ACCESS.2021.3062493

CrossRef Full Text | Google Scholar

4. Wang Y, Wang X, Gao T, Du L, Liu W. An automatic knee osteoarthritis diagnosis method based on deep learning: data from the osteoarthritis initiative. J Healthcare Eng (2021):e5586529. doi: 10.1155/2021/5586529

CrossRef Full Text | Google Scholar

5. Tiulpin A, Thevenot J, Rahtu E, Lehenkari P, Saarakkala S. Automatic knee osteoarthritis diagnosis from plain radiographs: A deep learning-based approach. Sci Rep (2018) 8. doi: 10.1038/s41598-018-20132-7

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Han Y, Zhou Y, Li H, Gong Z, Liu Z, Wang H. Identification of diagnostic mRNA biomarkers in whole blood for ankylosing spondylitis using WGCNA and machine learning feature selection. Front Immunol (2022) 13:956027. doi: 10.3389/fimmu.2022.956027

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Danve A, O’Dell J. The ongoing quest for biomarkers in Ankylosing Spondylitis. Int J Rheumatic Dis (2015) 18:826–34. doi: 10.1111/1756-185X.12779

CrossRef Full Text | Google Scholar

8. Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum (2007) 56:1846–53. doi: 10.1002/art.22589

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: A review. JAMA (2018) 320:1360–72. doi: 10.1001/jama.2018.13103

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet (2017) 389:2338–48. doi: 10.1016/S0140-6736(17)31491-5

PubMed Abstract | CrossRef Full Text | Google Scholar

11. D’Agostino MA, Terslev L, Wakefield R, Østergaard M, Balint P, Naredo E. Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Ann Rheumatic Dis (2016) 75:1902–8. doi: 10.1136/annrheumdis-2016-209646

CrossRef Full Text | Google Scholar

12. Cohen SB, Potter H, Deodhar A, Emery P, Conaghan P, Ostergaard M, et al. Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature review. doi: 10.1002/acr.20413

CrossRef Full Text | Google Scholar

13. Takase-Minegishi K, Horita N, Kobayashi K, Yoshimi R, Kirino Y, Ohno S, et al. Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: systematic review and meta-analysis. Rheumatology (2018) 57:49–58. doi: 10.1093/rheumatology/kex036

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Wenham CYJ, Grainger AJ, Conaghan PG. The role of imaging modalities in the diagnosis, differential diagnosis and clinical assessment of peripheral joint osteoarthritis. Osteoarthritis Cartilage (2014) 22:1692–702. doi: 10.1016/j.joca.2014.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Oinas J, Rieppo L, Finnilä MAJ, Valkealahti M, Lehenkari P, Saarakkala S. Imaging of osteoarthritic human articular cartilage using fourier transform infrared microspectroscopy combined with multivariate and univariate analysis. Sci Rep (2016) 6. doi: 10.1038/srep30008

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Lechowicz L, Chrapek M, Gaweda J, Urbaniak M, Konieczna I. Use of Fourier-transform infrared spectroscopy in the diagnosis of rheumatoid arthritis: a pilot study. Mol Biol Rep (2016) 43:1321–6. doi: 10.1007/s11033-016-4079-7

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Yuan Y, Yang L, Gao R, Chen C, Li M, Tang J, et al. Exploratory study on screening chronic renal failure based on fourier transform infrared spectroscopy and a support vector machine algorithm. J Spectrosc (2020) p:e7379242. doi: 10.1155/2020/7379242

CrossRef Full Text | Google Scholar

18. Stec P, Dudała J, Wandzilak A, Wróbel P, Chmura Ł, Szczerbowska-Boruchowska M. Fourier transform infrared microspectroscopy analysis of ovarian cancerous tissues in paraffin and deparaffinized tissue samples. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2023) 297:122717. doi: 10.1016/j.saa.2023.122717

CrossRef Full Text | Google Scholar

19. Synytsya A, Janstová D, Šmidová M, Synytsya A, Petrtýl J. Evaluation of IR and Raman spectroscopic markers of human collagens: Insides for indicating colorectal carcinogenesis. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2023) 296:122664. doi: 10.1016/j.saa.2023.122664

CrossRef Full Text | Google Scholar

20. Porcelli F, Verri M, De Santis S, Crescenzi A, Bianchi A, Felici AC. Considerations on chemical composition of psammoma bodies: Automated detection strategy by infrared microspectroscopy in ovarian and thyroid cancer tissues. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2023) 298:122792. doi: 10.1016/j.saa.2023.122792

CrossRef Full Text | Google Scholar

21. Synytsya A, Janstová D, Šmidová M, Synytsya A, Petrtýl J. Evaluation of IR and Raman spectroscopic markers of human collagens: Insides for indicating colorectal carcinogenesis. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2023), 122664. doi: 10.1016/j.saa.2023.122664

CrossRef Full Text | Google Scholar

22. Chen C, Yang L, Li H, Chen F, Chen C, Gao R. Raman spectroscopy combined with multiple algorithms for analysis and rapid screening of chronic renal failure,”. Photodiagnosis Photodyn Ther (2020) vol:101792. doi: 10.1016/j.pdpdt.2020.101792

CrossRef Full Text | Google Scholar

23. González-Viveros N, Castro-Ramos J, Gómez-Gil P, Cerecedo-Núñez HH, Gutiérrez-Delgado F. Quantification of glycated hemoglobin and glucose in vivo using Raman spectroscopy and artificial neural networks. Lasers Med Sci (2022) 37:3537–49. doi: 10.1007/s10103-022-03633-w

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Zhang J, Liu Y, Li H, Cao S, Li X, Yin H. Discrimination of periodontal pathogens using Raman spectroscopy combined with machine learning algorithms,”. J Innov Opt. Health Sci (2022) 15:2240001. doi: 10.1142/S1793545822400016

CrossRef Full Text | Google Scholar

25. Yang X, Ou Q, Yang W, Shi Y, Liu G. Diagnosis of liver cancer by FTIR spectra of serum,”. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2021) 263:120181. doi: 10.1016/j.saa.2021.120181

CrossRef Full Text | Google Scholar

26. McHardy RG, Antoniou G, Conn JJA, Baker MJ, Palmer DS. Augmentation of FTIR spectral datasets using Wasserstein generative adversarial networks for cancer liquid biopsies. Analyst (2023). doi: 10.1039/D3AN00669G

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Hu X, Zhu Y, Qian Y, Huang R, Yin S, Zeng Z, et al. Prediction of subsequent osteoporotic vertebral compression fracture on CT radiography via deep learning. VIEW (2022) 3:20220012. doi: 10.1002/VIW.20220012

CrossRef Full Text | Google Scholar

28. Wang L, Zhang M, Pan X, Zhao M, Huang L, Hu X, et al. Integrative serum metabolic fingerprints based multi-modal platforms for lung adenocarcinoma early detection and pulmonary nodule classification. Adv Sci (2022) 9:2203786. doi: 10.1002/advs.202203786

CrossRef Full Text | Google Scholar

29. Yang H, Li X, Zhang S, Li Y, Zhu Z, Shen J. A one-dimensional convolutional neural network based deep learning for high accuracy classification of transformation stages in esophageal squamous cell carcinoma tissue using micro-FTIR. Spectrochimica Acta Part A: Mol Biomolecular Spectrosc (2023), 122210. doi: 10.1016/j.saa.2022.122210

CrossRef Full Text | Google Scholar

30. Chen C, Yang B, Si R, Chen C, Chen F, Gao R. Fast detection of cumin and fennel using NIR spectroscopy combined with deep learning algorithms,”. Optik (2021) 242:167080. doi: 10.1016/j.ijleo.2021.167080

CrossRef Full Text | Google Scholar

31. Eren L, Ince T, Kiranyaz S. A generic intelligent bearing fault diagnosis system using compact adaptive 1D CNN classifier. J Sign Process Syst (2019) 91:179–89. doi: 10.1007/s11265-018-1378-3

CrossRef Full Text | Google Scholar

32. Zhang K, Tang B, Deng L, Liu X. A hybrid attention improved ResNet based fault diagnosis method of wind turbines gearbox,”. Measurement (2021) 179:109491. doi: 10.1016/j.measurement.2021.109491

CrossRef Full Text | Google Scholar

33. He K, Zhang X, Ren S, Sun J. (2016). Deep residual learning for image recognition, in: 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 770–8. doi: 10.1109/CVPR.2016.90

CrossRef Full Text | Google Scholar

34. Huang D, Zhang W-A, Guo F, Liu W, Shi X. “Wavelet packet decomposition-based multiscale CNN for fault diagnosis of wind turbine gearbox,”. IEEE Trans Cybernetics (2023) 53:443–53. doi: 10.1109/TCYB.2021.3123667

CrossRef Full Text | Google Scholar

35. Szegedy C, Liu W, Jia Y, Sermanet P, Reed S, Anguelov D. (2015). Going deeper with convolutions, in: 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 1–9. doi: 10.1109/CVPR.2015.7298594

CrossRef Full Text | Google Scholar

36. Lu Z, Yang T, Cao Z, Luo D, Zhang Q, Liang Y. Optical soft tactile sensor algorithm based on multiscale resnet. IEEE Sensors Journal (2023) 23:10731–8. doi: 0.1109/JSEN.2023.3264635

Google Scholar

37. Virtanen V, Tafintseva V, Shaikh R, Nippolainen E, Haas J, Afara IO. Infrared spectroscopy is suitable for objective assessment of articular cartilage health,”. Osteoarthritis Cartilage Open (2022) 4. doi: 10.1016/j.ocarto.2022.100250

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Chen F, Meng C, Qu H, Cheng C, Chen C, Yang B. Human serum mid-infrared spectroscopy combined with machine learning algorithms for rapid detection of gliomas. Photodiagnosis Photodyn Ther (2021) 35:102308. doi: 10.1016/j.pdpdt.2021.102308

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Panizzi L, Vignes M, Dittmer KE, Waterland MR, Rogers CW, Sano H. Infrared spectroscopy of serum fails to identify early biomarker changes in an equine model of traumatic osteoarthritis. Osteoarthritis Cartilage Open (2022) 4:100297. doi: 10.1016/j.ocarto.2022.100297

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Coates J. Interpretation of infrared spectra, A practical approach. In: Encyclopedia of analytical chemistry. John Wiley & Sons, Ltd (2006). doi: 10.1002/9780470027318.a5606

CrossRef Full Text | Google Scholar

41. Prada P, Brunel B, Moulin D, Rouillon L, Netter P, Loeuille D, et al. Identification of circulating biomarkers of Crohn’s disease and spondyloarthritis using Fourier transform infrared spectroscopy. J Biophotonics (2023) 16:e202200200. doi: 10.1002/jbio.202200200

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Derruau S, Gobinet C, Untereiner V, Sockalingum GD, Nassif A, Viguier M, et al. New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study. J Biophotonics (2021) 14:e202000327. doi: 10.1002/jbio.202000327

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Nallala J, Piot O, Diebold MD, Gobinet C, Bouché O, Manfait M, et al. Infrared imaging as a cancer diagnostic tool: Introducing a new concept of spectral barcodes for identifying molecular changes in colon tumors. Cytometry Part A (2013) 83A:294–300. doi: 10.1002/cyto.a.22249

CrossRef Full Text | Google Scholar

44. Alexandropoulou I, Grammatikopoulou MG, Gkouskou KK, Pritsa AA, Vassilakou T, Rigopoulou E, et al. Ceramides in autoimmune rheumatic diseases: existing evidence and therapeutic considerations for diet as an anticeramide treatment. Nutrients (2023) 15. doi: 10.3390/nu15010229

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U, et al. Sphingolipids in human synovial fluid - A lipidomic study. PloS One (2014) 9:e91769. doi: 10.1371/journal.pone.0091769

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Takahashi Y, Sugano N, Takao M, Sakai T, Nishii T, Pezzotti G. Raman spectroscopy investigation of load-assisted microstructural alterations in human knee cartilage: Preliminary study into diagnostic potential for osteoarthritis. J Mechanical Behav Biomed Materials (2014) 31:77–85. doi: 10.1016/j.jmbbm.2013.02.014

CrossRef Full Text | Google Scholar

47. Koh JH, Yoon SJ, Kim M, Cho S, Lim J, Park Y, et al. Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis. Exp Mol Med (2022) 54:143–55.

PubMed Abstract | Google Scholar

48. Kelly B, Pearce EL. Amino assets: how amino acids support immunity. Cell Metab (2020) 32(2):154–75. doi: 10.1016/j.cmet.2020.06.010

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin biochemist. Rev (2005) 26(4):97–122.

Google Scholar

50. Xu X, Wang M, Wang Z, Chen Q, Chen X, Xu Y, et al. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis. Front Immunol (2022) 13:1007610. doi: 10.3389/fimmu.2022.1007610

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M, Fuchs D. Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol (2006) 25:334–7. doi: 10.1007/s10067-005-0056-6

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Rushing BR, McRitchie S, Arbeeva L, Nelson AE, Azcarate-Peril MA, Li YY, et al. Fecal metabolomics reveals products of dysregulated proteolysis and altered microbial metabolism in obesity-related osteoarthritis. Osteoarthritis cartilage (2022) 30(1):81–91. doi: 10.1016/j.joca.2021.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Berlinberg AJ, Regner EH, Stahly A, Brar A, Reisz JA, Gerich ME, et al. Multi ‘Omics analysis of intestinal tissue in ankylosing spondylitis identifies alterations in the tryptophan metabolism pathway. Front Immunol (2021) 12:587119. doi: 10.3389/fimmu.2021.587119

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Mustonen AM, Käkelä R, Lehenkari P, Huhtakangas J, Turunen S, Joukainen A, et al. Distinct fatty acid signatures in infrapatellar fat pad and synovial fluid of patients with osteoarthritis versus rheumatoid arthritis. Arthritis Res Ther (2019) 21(1):124. doi: 10.1186/s13075-019-1914-y

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Lei Q, Yang J, Li L, Zhao N, Lu C, Lu A, et al. Lipid metabolism and rheumatoid arthritis. Frontiers in immunology (2023) 14:1192607. doi: fimmu.2023.1190607

Google Scholar

56. Lee Y-R, Findlay DM, Muratovic D, Gill TK, Kuliwaba JS. Raman microspectroscopy demonstrates reduced mineralization of subchondral bone marrow lesions in knee osteoarthritis patients. Bone Rep (2020) 12:100269. doi: 10.1016/j.bonr.2020.100269

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Cao L, Zheng X, Han P, Ren L, Wang J, Hu F, et al. Raman spectroscopy as a promising diagnostic method for rheumatoid arthritis. Anal Methods (2023) 15:709–18. doi: 10.1039/D2AY01904C

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Fourier transform infrared spectroscopy, ankylosing spondylitis, rheumatoid arthritis, osteoarthritis, multiscale fusion, deep learning, diagnosis

Citation: Wu X, Shuai W, Chen C, Chen X, Luo C, Chen Y, Shi Y, Li Z, Lv X, Chen C, Meng X, Lei X and Wu L (2023) Rapid screening for autoimmune diseases using Fourier transform infrared spectroscopy and deep learning algorithms. Front. Immunol. 14:1328228. doi: 10.3389/fimmu.2023.1328228

Received: 26 October 2023; Accepted: 27 November 2023;
Published: 15 December 2023.

Edited by:

Juan C. Cruz, University of Los Andes, Colombia

Reviewed by:

Kun Qian, Shanghai Jiao Tong University, China
Carolina Muñoz-Camargo, University of Los Andes, Colombia

Copyright © 2023 Wu, Shuai, Chen, Chen, Luo, Chen, Shi, Li, Lv, Chen, Meng, Lei and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lijun Wu, wwlj330@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.